[Diagnosis and treatment of aplastic anemia]
- PMID: 3070360
[Diagnosis and treatment of aplastic anemia]
Abstract
Severe aplastic anemia is a rare disorder in childhood. Among various therapeutical strategies bone marrow transplantation (BMT) and immunosuppressive treatment with antithymocyte globulin (ATG) have proven to be most successful. Priority should be given to BMT over ATG treatment for patients with HLA-identical donors. Patients with Fanconi's anemia require a reduced conditioning program with cyclophosphamide and irradiation for BMT. Own experiences indicate that cooperative studies are highly needed to improve medical care for patients with severe aplastic anemia.
Similar articles
-
[Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].Rev Clin Esp. 1989 Feb;184(3):121-4. Rev Clin Esp. 1989. PMID: 2655043 Spanish.
-
Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.Haematologica. 2001 Apr;86(4):434-5. Haematologica. 2001. PMID: 11325653
-
Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia.Bone Marrow Transplant. 2004 Dec;34(11):939-43. doi: 10.1038/sj.bmt.1704720. Bone Marrow Transplant. 2004. PMID: 15489866
-
Treatment of acquired severe aplastic anemia.Am J Pediatr Hematol Oncol. 1989 Fall;11(3):360-7. Am J Pediatr Hematol Oncol. 1989. PMID: 2675662 Review.
-
Antithymocyte globulin: a realistic approach to therapy for severe aplastic anemia.South Med J. 1986 Sep;79(9):1121-5. South Med J. 1986. PMID: 3529435 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials